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Case
A 12 year-old boy who had been diagnosed as juvenile
idiopathic arthritis (JIA) nine years ago, had attended to
our hospital with the complaints of high fever, arthralgia
and abdominal pain. He was febrile with salmon colored
maculopapular rash all over the body. He was evaluated
for infections and malignancy. He was diagnosed as sys-
temic onset JIA (SoJIA). Pulse steroid therapy was
started. He was fine at the second day of pulse therapy,
at the 3rd day his rash recurred and he became febrile
all day long. We detected pancytopenia, low ESR, hyper-
ferritinemia, high D-dimer, low fibrinogen and hypertri-
glyceridemia. His pulse was prolonged to 5 days and
cyclosporin (5 mg/kg) was commenced with the diagno-
sis of macrophage activation syndrome. He became
worse clinically and his ferritin levels continued to rise.
Intraveneous immunoglobulin (2 gr/day) was added but
he was resistant. Hemophagocytic lymphohistiocytosis
protocol was started. His ferritin was elevated until
135.000 ng/ml. Etanercept treatment (o.4 mg/kg twice a
week) was introduced. With renewal of the laboratory
findings we decided to start hemofiltration and plasma-
pheresis in order to deecrease the cytokine overload. He
was taken under continious hemofiltration and plasma-
pheresis. After 22 days in the PICU his ferritin levels
decreased to 1500 ng/ml. He had arthralgias and eleva-
tion of acute phase responseo n c em o r e ,t h i sp i c t u r e
was attributed to activation of SoJIA and metotrexate
therapy was started. We presented our very resistant
case to point out the success of a novel therapeutic
approach that is plasmapheresis and hemofiltration.
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